Posts tagged with ‘marine natural product’

  • PharmaMar and Costa Rica to search ocean in search of cancer cures

    Experts from Costa Rica and the Spanish company PharmaMar, dedicated to marine biotechnology research, beginning in February will seek new cures and treatments for cancer in organisms living in Costa Rican waters. The Spanish company will work for five years in the territorial waters of Costa Rica thanks to an agreement with the National Institute of Biodiversity (INBio), promoted by […]
    0
  • 2012 Symposium on Marine Natural Product Drug Discovery in Aberdeen, Nov 6th

    The 2012 Symposium on Marine Natural Product Drug Discovery will bring together academics and industry representatives from across Europe to discuss groundbreaking research into the development of novel drug candidates from marine natural resources, with particular emphasis on the fields of cancer and on neurodegenerative diseases. The symposium, which is held in the context of the biannual Pharmatlantic consortium meeting, will take […]
    0
  • Mar. Drugs, Volume 10, Issue 8 (August 2012), Pages 1619-1898 Newly Released

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 10, Issue 8 (August 2012), Pages Pages 1619-1898 TOC: Anthony D. Wright, Jonathan L. Nielson, Dianne M. Tapiolas, Catherine H. Liptrot and Cherie A. Motti Article: A Great Barrier Reef Sinularia sp. Yields Two New Cytotoxic Diterpenes Mar. Drugs 2012, 10(8), 1619-1630; doi:10.3390/md10081619 http://www.mdpi.com/1660-3397/10/8/1619/ Vânia Cristina Desoti, […]
    0
  • BIOPROSP ’13 Conference Registration Now Open

    The 6th BIOPROSP Conference A biennial International Conference on Marine Bioprospecting from cold marine environment. To be held in the world’s northernmost University City in February 20th – 22nd in Tromsø, Norway. Conference objective: BIOPROSP_13 will focus on the challenges and possibilities related to industrial applications of marine bioactive compounds Target group: Biotech and pharmaceutical industry, scientists, medicine, cosmetics, public […]
    0
  • Aquapharm announces discovery of novel antibiotic compound

    Scottish biotechnology company Aquapharm Biodiscovery has discovered a novel antibiotic compound with potent activity against a broad spectrum of multi-drug-resistant Gram-positive bacteria. The compound, which demonstrates bactericidal potency against Multi Drug Resistant Staphylococcus Aureus (MDRSA) and Multi Drug Resistant Streptococcus Pneumoniae (MDRSP), Clostridium Difficile and Enteroccocus Faecalis which are common causes of death in patients in hospital care units is the company’s first new […]
    0
  • Aquapharm and c-LEcta collaboration on marine-derived biocatalysts

    In a pioneering collaboration the leading Scottish biotechnology company Aquapharm and German industrial biotechnology firm c-LEcta are set to fast-track the discovery and commercialisation of a new wave of bio-catalysts. c-LEcta is skilled in the identification and engineering of enzymes and strains for optimized bio-catalytic industry processes, whilst Aquapharm has proven expertise in harnessing the commercial potential of its unique […]
    0
  • Mar. Drugs, Volume 10, Issue 7 (July 2012), Pages 1422-1618 Released

    MDPI is pleased to announce the publication of the following issue: Mar. Drugs, Volume 10, Issue 7 (July 2012), Pages Pages 1422-1618 http://www.mdpi.com/1660-3397/10/7/ Table of Contents: Rui Li, Chang-Lun Shao, Xin Qi, Xiu-Bao Li, Jing Li, Ling-Ling Sun and Chang-Yun Wang Article: Polyoxygenated Sterols from the South China Sea Soft Coral Sinularia sp. Mar. Drugs 2012, 10(7), 1422-1432; doi:10.3390/md10071422 http://www.mdpi.com/1660-3397/10/7/1422/ Shang-Kwei […]
    0
  • Norway’s MareLife issues summer newsletter summarizing recent marine biotech-related activities and projects

    Marelife, the independent science-based marine innovation network, has reinforced its staff and put in operation R&D projects initiated by experienced working groups covering key areas in marine innovation. Read their new summer newsletter which sums up the Marelife activities Winter and Spring 2012. More info
    0
  • Biotec Pharmacon files first part of registration file for Woulgan Biogel

    Biotec BetaGlucans AS, wholly owned subsidiary of Biotec Pharmacon ASA, has today filed the first part of the registration file for its new and novel Woulgan® Biogel product. Svein Lien, CEO of Biotec Pharmacon says: “This is an important milestone in our efforts to commercialize our novel beta-glucans for advanced wound healing. This is a market in need of new […]
    0
  • Mar. Drugs, Volume 10, Issue 6 (June 2012), Pages Pages 1192-1421 Now Available

    MDPI is pleased to announce the availability of the following: Mar. Drugs, Volume 10, Issue 6 (June 2012), Pages Pages 1192-1421 http://www.mdpi.com/1660-3397/10/6/ Table of Contents: Sheila Marie Pimentel-Elardo, Lubomir Grozdanov, Sebastian Proksch and Ute Hentschel Article: Diversity of Nonribosomal Peptide Synthetase Genes in the Microbial Metagenomes of Marine Sponges Mar. Drugs 2012, 10(6), 1192-1202; doi:10.3390/md10061192 http://www.mdpi.com/1660-3397/10/6/1192/ Shwu-Li Wu, Jui-Hsin Su, […]
    0